Browsing by Subject "stereotactic body radiation therapy"
Results Per Page
Sort Options
Item Open Access A current perspective on stereotactic body radiation therapy for pancreatic cancer.(Onco Targets Ther, 2016) Hong, Julian C; Czito, Brian G; Willett, Christopher G; Palta, ManishaPancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable to undergo resection, which remains the only potentially curative treatment option. The management of locally advanced (unresectable) pancreatic cancer is controversial; however, treatment with either chemotherapy or chemoradiation is associated with high rates of local tumor progression and metastases development, resulting in low survival rates. An emerging local modality is stereotactic body radiation therapy (SBRT), which uses image-guided, conformal, high-dose radiation. SBRT has demonstrated promising local control rates and resultant quality of life with acceptable rates of toxicity. Over the past decade, increasing clinical experience and data have supported SBRT as a local treatment modality. Nevertheless, additional research is required to further evaluate the role of SBRT and improve upon the persistently poor outcomes associated with pancreatic cancer. This review discusses the existing clinical experience and technical implementation of SBRT for pancreatic cancer and highlights the directions for ongoing and future studies.Item Open Access Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy.(Physics in medicine and biology, 2019-01-08) Lafata, Kyle J; Hong, Julian C; Geng, Ruiqi; Ackerson, Bradley G; Liu, Jian-Guo; Zhou, Zhennan; Torok, Jordan; Kelsey, Chris R; Yin, Fang-FangThe purpose of this work was to investigate the potential relationship between radiomic features extracted from pre-treatment x-ray CT images and clinical outcomes following stereotactic body radiation therapy (SBRT) for non-small-cell lung cancer (NSCLC). Seventy patients who received SBRT for stage-1 NSCLC were retrospectively identified. The tumor was contoured on pre-treatment free-breathing CT images, from which 43 quantitative radiomic features were extracted to collectively capture tumor morphology, intensity, fine-texture, and coarse-texture. Treatment failure was defined based on cancer recurrence, local cancer recurrence, and non-local cancer recurrence following SBRT. The univariate association between each radiomic feature and each clinical endpoint was analyzed using Welch's t-test, and p-values were corrected for multiple hypothesis testing. Multivariate associations were based on regularized logistic regression with a singular value decomposition to reduce the dimensionality of the radiomics data. Two features demonstrated a statistically significant association with local failure: Homogeneity2 (p = 0.022) and Long-Run-High-Gray-Level-Emphasis (p = 0.048). These results indicate that relatively dense tumors with a homogenous coarse texture might be linked to higher rates of local recurrence. Multivariable logistic regression models produced maximum [Formula: see text] values of [Formula: see text], and [Formula: see text], for the recurrence, local recurrence, and non-local recurrence endpoints, respectively. The CT-based radiomic features used in this study may be more associated with local failure than non-local failure following SBRT for stage I NSCLC. This finding is supported by both univariate and multivariate analyses.Item Open Access Peritumoral CT Radiomic Modelling for Non-local Treatment Failure of Early Stage Non-Small Cell Lung Cancers(2020) Gao, YinBackground: Quantitative medical imaging has been increasingly utilized in modern medicine. The field of radiomics is an emerging subset of quantitative medical imaging. Radiomics can identify a large number of quantitative features as the biomarkers from the radiography images. Subsequent mining and analysis of these features may potentially uncover subclinical tumor characteristics of disease in a non-invasive manner, and provide clinical decision support. Biomarkers on gross tumor regions have been studied for many years for different clinical endpoints. Correlations between the radiomic features and treatment outcomes, disease diagnosis, pathological information, and organ functions can be studied for clinical decision support. Peritumor region is the region around the gross tumor, where may also be used to extract radiomics biomarkers. Currently, limited studies are available in this area. Machine learning is a powerful tool to correlate radiomics features with various clinical endpoints and provide a predictive model to better define tumor characteristics.
Purpose: To investigate the association between CT radiomic data from peritumoral regions and non-local treatment failure recurrence of early stage non-small cell lung cancers (NSCLC) following lung stereotactic body radiation therapy (SBRT), to identify secondary quantitative parameters from the dose-driven peritumoral CT radiomic data, to compare the model performance of using radiomic data with and without secondary quantitative parameters for assessing the non-local treatment failure following lung SBRT.
Materials and Methods: Sixty-three patients who received SBRT for early-stage NSCLC were retrospectively identified by an IRB approved clinical trial with treatment outcome provided. Treatment failure was defined as both local cancer recurrence and non-local cancer recurrence following SBRT. Gross Tumor Volumes (GTVs) were segmented on the pre-treatment free-breathing CT images by radiation oncologists. Two types of peritumoral volumes were defined on pre-treatment free-breathing CT: uniform ring and dose-driven. The uniform ring peritumoral volumes were generated by expanding GTVs at radial distances of 3mm, 6mm, 9mm and 12mm. The dose-driven peritumoral volumes were generated by converting ten isodose volumes (100%, 98%, 95%, 90%, 85%, 80%, 70%, 50%, 30%, and 10%) into structures in the treatment planning system. All peritumoral volumes were then modified using a Boolean process to exclude the GTV and non-lung tissue. Sixty radiomic features (4 Intensity, 21 GLCOM, 11 GLRLM, 13 GLSZM, 5 NGLDM, and 6 Shape) were extracted from GTVs and peritumoral volumes using an in-house radiomics calculation platform as biomarkers for cancer recurrence. A univariate feature selection was used to eliminate highly correlated features. Two multivariate machine learning based feature selection algorithms were followed to find the important features and to avoid overfitting. Machine learning algorithms (Random Forest, LASSO Logistic Regression, Ridge Logistic Regression, Linear Support Vector Machine and Kernel Support Vector Machine) were used to build classification models to predict non-local treatment failure. 63 patients were randomly separated into the training group (75%) and the test group (25%). Model generalization was cross validated using a stratified 10-fold with 50 iterations. The learning curve and grid search were used to find the best hyperparameters to enhance the model performance and avoid the overfitting in the random forest model. The performance of each feature selection and classifier combination was based on the area under the receiver operating characteristic curve (ROC). Pair t-tests with 100 iteration permutation tests were used to evaluate the significant difference between different AUCs.
Results: In uniform expansion ring peritumoral region, from the results, 3mm ring was more predictive of non-local treatment failure than all peritumoral radiomic data and gross tumor radiomic data. In dose-driven peritumoral region, from the results, 80% isodose region was more predictive of non-local treatment failure than all peritumoral radiomic data and gross tumor radiomic data. The model combinations of tree-based feature selection and Random Forest classifier presented the highest AUC values. No significant difference in predictive performance was found before and after adding secondary features in the dataset (p-value > 0.05). However, secondary features may be useful in other studies given that obvious patterns were seen in the clustering heatmap.
Conclusions: This study has demonstrated strong prognostic value of peritumoral radiomics for non-local treatment failure in patients with stage I NSCLC. The presented peritumoral radiomics was shown to have better predictive performance compared to the gross tumor radiomics.
Keywords: Radiomics, peritumoral region, machine learning, stereotactic body radiation therapy, non-small cell lung cancer